Primis Financial Corp Dossier - Source-backed chat

Primis Financial Corp

FRSTNASDAQ

SectorFinancials

IndustryRegional Banks

Beta (adjusted)0.83

Intrinsic Value $16.34median of 2 methodsbased on filings through 30 Jun 2026

Market Price $15.39Price as of 1 Oct 2026

Near fair valueIntrinsic value is 6% above the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

Data confidence Sign in to view data confidence

Market Cap $381.7M

Shares Outstanding 24.7M diluted

Next Earnings Date22 Oct 2026

Last ex-dividend7 Aug 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Primis Financial Corp. (NASDAQ: FRST) is executing a successful strategic pivot away from high-cost consumer programs toward high-yielding specialty verticals, notably Panacea Financial (medical professional lending) and its mortgage warehouse division. The company's Q1 2026 results demonstrate robust operational momentum, highlighted by a 126% year-over-year surge in operating net income and significant net interest margin (NIM) expansion to 3.43%. Backed by a stable core deposit base with zero brokered deposits and low investor commercial real estate (CRE) concentrations, Primis is well-positioned to achieve its 1.0% ROAA target for 2026. Trading at an attractive valuation relative to regional peers, the stock offers a compelling risk-reward profile as its high-margin specialty lending platforms scale.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets4 analysts · as of 18 Aug 2026

Low · most bearish analyst$18.00

Mean target$19.19

High · most bullish analyst$20.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

Broader macroeconomic headwinds or regional banking pressures lead to deposit migration, forcing Primis to raise deposit yields and compress margins. Mortgage market stagnation limits production volumes below targets, and credit quality deteriorates in the specialty loan portfolios, requiring higher provisions that drag ROAA below 0.70%.

Base CaseCentral scenario

The core bank maintains stable deposit costs near 1.59% while Panacea and mortgage warehouse divisions continue their double-digit growth trajectories. NIM expands toward the 3.45%-3.50% range by year-end, and the company successfully achieves its 1.0% ROAA target. Operating expenses remain well-controlled within the projected $22-$23 million quarterly range, driving steady tangible book value expansion.

Bull CaseUpside scenario

Primis Financial Corp. presents a compelling bull case driven by robust Q2 2026 financial performance, including a 34% YoY increase in net interest income to $33.8 million and NIM expansion to 3.45%. Credit quality has improved significantly, with nonperforming assets declining 37% quarter-over-quarter to 1.45% of total assets. Furthermore, the stock trades at a price-to-tangible book value of 1.17x, representing a 28% discount to the peer group average of 1.5x, offering substantial valuation upside and potential for multiple expansion.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Strong NIM expansion driven by robust earning asset growth funded at attractive incremental margins (NIM up 28 bps YoY to 3.43% in Q1 2026).
High-growth specialty lending platforms like Panacea Financial (reaching $600 million in loans) and Mortgage Warehouse (up 300% YoY to $460 million).
Excellent deposit franchise quality with a low cost of deposits (1.59% in Q1 2026) and zero reliance on brokered deposits.
Low concentration of risky investor Commercial Real Estate (CRE) loans, representing only 25% of total loans and 197% of regulatory capital.

Key Investment Risks

Sensitivity to interest rate volatility which could impact mortgage production volumes and warehouse lending demand.
Execution risk associated with scaling digital-only platforms and the proprietary commercial depositor app.
Potential credit quality normalization in specialty medical and professional loan portfolios.

Thesis Invalidation Triggers

Core bank deposit costs rising above 2.20%, indicating severe funding pressure.
NIM compressing below 3.15% for two consecutive quarters.
A material rise in nonperforming assets (NPAs) or net charge-offs (NCOs) within the Panacea portfolio exceeding historical peer averages.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.